UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000010881
Receipt No. R000012733
Scientific Title Study on influence of drugs on antiplatelet effects of aspirin.
Date of disclosure of the study information 2013/06/05
Last modified on 2018/12/25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study on influence of drugs on antiplatelet effects of aspirin.
Acronym Study on influence of drugs on antiplatelet effects of aspirin.
Scientific Title Study on influence of drugs on antiplatelet effects of aspirin.
Scientific Title:Acronym Study on influence of drugs on antiplatelet effects of aspirin.
Region
Japan

Condition
Condition Healthy volunteers
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate influence of nonsteroidal anti-inflammatory drugs, health food, selective serotonin reuptake inhibitor (SSRI),
or noradrenergic and specific serotonergic antidepressant (NaSSA) on antiplatelet effect of aspirin.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Platelet aggregation activity(Platelet Aggregation Threshold Index:PATI)
Key secondary outcomes Serum thromboxane B2 concentration

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Healthy volunteers.
2)Subjects who signed, based on his/her free will, to the clinical trial agreement with full understanding of the purpose of this conducted trial and its insights.
Key exclusion criteria 1)Subjects who have donated 200 mL blood within 1 month, or 400 mL blood within 3 month.
2)Subjects who have taken aspirin or drugs with antiplatelet effect within 1 week.
3)Subjects with hypertension or hypotension.
4)Subjects with poor condition on a blood collecting day.
5)Subjects whom the doctor considered to be unsuitable for this study.
6)Subjects who are unable to put restrictions on diets (ex. foods and drinks are prohibited within 4 hours prior to blood collection, high fat meals should be avoided since 1 day before blood collection).
Target sample size 10

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Takao Aoyama
Organization Tokyo University of Science
Division name Faculty of Pharmaceutical Sciences
Zip code
Address 2641 Yamazaki Noda City, Chiba Pref., 278-8510, Japan
TEL 04-7121-3659
Email t-aoyama@rs.noda.tus.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Takao Aoyama
Organization Tokyo University of Science
Division name Faculty of Pharmaceutical Sciences
Zip code
Address 2641 Yamazaki Noda City, Chiba Pref., 278-8510, Japan
TEL 04-7121-3659
Homepage URL
Email t-aoyama@rs.noda.tus.ac.jp

Sponsor
Institute Laboratory of pharmacotherapeutics, Tokyo University of Science
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor None
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京理科大学薬物治療学研究室

Other administrative information
Date of disclosure of the study information
2013 Year 06 Month 05 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2013 Year 06 Month 05 Day
Date of IRB
Anticipated trial start date
2013 Year 06 Month 05 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information To investigate influence of nonsteroidal anti-inflammatory drugs or statins on antiplatelet effect of aspirin.

Platelet aggregation activity(Platelet Aggregation Threshold Index:PATI)

Management information
Registered date
2013 Year 06 Month 05 Day
Last modified on
2018 Year 12 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012733

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.